World of DTC Marketing

SEPTEMBER 12, 2022

Apple’s Health app gets new capabilities with iOS 16. The Health app adds Medications, allowing users to conveniently build and manage a medications list, create schedules and reminders, and track their medications, vitamins, or supplements. Will it matter? The health app will also tell users about potential interactions between medications, and it’s possible to connect with healthcare providers to see a list of past medications, get future updates, or add items to your schedule.

Medical 166

Medical Healthcare Provider Doctors Physicians 166

Pharmaceutical Technology

SEPTEMBER 13, 2022

Novo Nordisk has signed a new strategic partnership with Microsoft to expedite the discovery and development of drugs leveraging big data and artificial intelligence (AI). Under the deal, Microsoft's computational services, Cloud and artificial intelligence (AI) will be merged with the drug discovery, development and data science expertise of Novo Nordisk.

Training 139

Training Leads Pharmaceutical Patients 139

PharmExec

SEPTEMBER 10, 2022

FDA backs the benefits of adopting continuous manufacturing, a strategy which has accelerated approval and launch timelines, and its Emerging Technology Program could be a helpful tool.

Manufacturing 130

Manufacturing Marketing FDA 130

pharmaphorum

SEPTEMBER 16, 2022

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares. A mere six months ago Verily launched the study with Sosei Heptares – a global leader in GPCR structure-based drug design – with an aim to “prioritise protein targets for therapeutic targeting in immune-mediated disease”.

Leads 124

Leads Patients Medicine FDA 124

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

MedCity News

SEPTEMBER 16, 2022

The problem with the US healthcare system is one of misaligned incentives. Prescribers are paid to evaluate patients and to administer care. All prescribers want the best outcomes for their patients, but the system does not incentivize choosing the best medications to promote those outcomes. Instead it is incentivized to pay for only the medications prescribed.

Healthcare 120

Healthcare Healthcare Medical Patients 120

Medgadget

SEPTEMBER 10, 2022

Researchers at the University of Bern in Switzerland have developed a motion tracking system that is intended to assist in detecting age-related disease in elderly people. The system could be installed in someone’s home or in assisted-living facilities, and consists of a series of motion sensors that can monitor for signs of unusual movement. The system can inform caregivers if an emergency arises, such as a fall, which can be detected when someone does not return to their bed at night or is sta

Medicine 115

Medicine Healthcare Healthcare Medical 115

European Pharmaceutical Review

SEPTEMBER 12, 2022

Novartis has revealed plans to invest $300 million in next-generation biotherapeutics. The multi-year investment will be implemented across existing Novartis locations in Switzerland, Slovenia and Austria to create a fully integrated, “dedicated scientific environment will bolster its capacity and capabilities for early technical development of biologics”.

Manufacturing 108

Manufacturing Pharmaceutical Patients 108

MedCity News

SEPTEMBER 13, 2022

By following the patient at each stage of its disease progression, from diagnosis to disease management, and integrating a variety of technologies, digital health provides deeper insights and help for care management.

Management 118

Management Patients 118

Medgadget

SEPTEMBER 13, 2022

Researchers at the University of the Basque Country have developed a technique that allows them to 3D print pharmaceutical tablets using different types of starch. By modifying the types of starch used and the shape of the tablets, the team can fine-tune drug release to be either rapid or slow. This includes full release of the encapsulated drug in as little as ten minutes to as long as six hours, providing significant scope to address a wide variety of therapeutic situations.

Medicine 108

Medicine Specialization Patients Networking 108

Pharmaceutical Technology

SEPTEMBER 15, 2022

Last year was a positive year for biopharmaceutical companies, particularly those with Covid-19 vaccines. The top 13 players reported more than 10% revenue growth, with BioNTech (3,834.4%), Moderna (2,199.1%), Pfizer (95.2%) and Regeneron Pharmaceuticals (89.1%) reporting a more than 80% year-on-year (YoY) revenue growth from 2020 to 2021, according to GlobalData’s Pharma Intelligence Centre Companies Database.

Sales 108

Sales Competition Pharmaceutical Pharmaceutical research 108

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

Copyright Clearance Center

SEPTEMBER 13, 2022

Sept. 13, 2022 – Danvers, Mass. – CCC , a leading provider of Open Access (OA) workflow solutions, has launched OA Agreement Intelligence , the only agreement modeling solution that enables publishers to prepare, build, and analyze their OA data so that they can create and communicate sustainable and transparent agreements with their partners. The solution combines sophisticated data preprocessing with easy-to-use analysis and export capabilities.

Management 105

Management Leads Marketing 105

MedCity News

SEPTEMBER 16, 2022

Medsembly, an Atlanta-based startup that connects students who want to get into healthcare with working professionals in their prospective careers, launched an interactive digital mentoring platform. The platform allows students to connect with healthcare professionals who can give them advice on things like how to get into medical school, how to land a residency and what day-to-day activities they can expect in their prospective career.

Healthcare 100

Healthcare Healthcare Prospecting Medical 100

pharmaphorum

SEPTEMBER 14, 2022

A $14 million research project is getting underway in the US to see whether cancer and other diseases can be diagnosed by picking up subtle changes in a person’s voice patterns. The National Institutes of Health (NIH)-funded project is being run by researchers at the University of South Florida in collaboration with Weill Cornell Medicine in New York City, 10 other institutions in the US and Canada, and with the help of French/US artificial intelligence specialist Owkin.

Ethics 101

Ethics Doctors Training Medical 101

PharmaVoice

SEPTEMBER 16, 2022

The serial entrepreneur has relied on his gift for storytelling, creativity and a bit of “magic” as he’s launched one successful niche tech company after another.

98

98

Advertiser: ZoomInfo

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

Competition

PM360

SEPTEMBER 15, 2022

The virtual workplace was a two-year experiment. Now, the next one begins: hybrid work. Partly in the office, partly from home—it seems to be the way forward. So how should organizational leaders support the hybrid work model to make the most of it? To explore this question, we launched a longitudinal study of the U.S. workforce. Our results suggested that when employees felt their leaders actively supported the virtual work environment, they were more engaged and innovative, experienced less bu

Pharma 98

Pharma Management Manufacturing 98

MedCity News

SEPTEMBER 16, 2022

Yuvo Health launched a new initiative to provide FQHCs with administrative and managed contract services to help them adopt value-based care. The New York startup partnered with the Primary Care Development Corporation to co-develop training programs and support resources to ensure FQHCs are positioned for success in these care models.

Training 99

Training Management 99

PharmaTech

SEPTEMBER 15, 2022

You have your drug substance and need a parenteral formulation to administer it. This podcast will focus on the key factors to consider when choosing the ideal parenteral manufacturing CDMO partner.

Manufacturing 98

Manufacturing 98

PharmaVoice

SEPTEMBER 16, 2022

The CEO of Eversana has made his mark on the life sciences by disrupting the status quo for commercialization — and he’s got more industry-shifting changes in the works.

98

98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

PM360

SEPTEMBER 15, 2022

The term “patient centricity” has been around for over a decade, and since its first utterance the buzzword has been praised, dissected, criticized, and everything in between. The concept has always been worthwhile, but people within and outside of the industry have wondered whether the industry was truly becoming more patient centric? If its patient-centric strategies were actually working?

Patients 98

Patients Healthcare Healthcare Marketing 98

MedCity News

SEPTEMBER 15, 2022

CarePoint Health, a three-hospital health system in New Jersey, recently filed a lawsuit against RWJBarnabas Health, the largest acute care provider in the state. The complaint alleged that RWJBarnabas conspired with real estate investors, New Jersey’s largest payer and government officials to eliminate competition and monopolize acute care services in the state.

Government 98

Government Competition 98

Legacy MEDSearch

SEPTEMBER 13, 2022

Potrero Medical announced that the FDA granted Breakthrough Device Designation for their AKI Predict machine learning algorithm, for the advanced prediction of acute kidney injury (AKI) associated with intra-abdominal hypertension (IAH) in cardiac post-surgical intensive care patients. Joe Urban, Potrero CEO stated “We celebrate the breakthrough designation, and we are excited about what this will mean for patients, providers and health systems in the future.” Urban further commented

Medical 98

Medical FDA Recruitment Management 98

PharmaVoice

SEPTEMBER 14, 2022

As the first chief medical officer of the diagnostic testing company, Dr. Katharine Knobil is focused on moving the science forward beyond precision oncology to liquid biopsy.

Medical 98

Medical 98

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

Pharmaceutical Technology

SEPTEMBER 14, 2022

Tumour-infiltrating lymphocyte (TIL) therapy has been investigated as a treatment modality for melanoma for almost 20 years. As an autologous cell therapy, manufacturing the infusion product is a highly specialised process involving tumour harvest and the extraction and large-scale ex vivo expansion of TILs. Before TIL infusion, the patient undergoes lymphodepletion, which reduces the proportion of myeloid immune suppressive cells and creates space for the incoming lymphocytes.

Manufacturing 98

Manufacturing Patients Engineering Pharma 98

MedCity News

SEPTEMBER 11, 2022

A key part of the ruling by Judge Reed O’Connor of the U.S. District Court for the Northern District of Texas says one way that preventive services are selected for the no-cost coverage is unconstitutional. Another portion of his ruling says a requirement that an HIV prevention drug therapy be covered without any cost to patients violates the religious freedom of an employer who is a plaintiff in the case.

Patients 98

Patients Medical 98

Pharmaceutical Commerce

SEPTEMBER 14, 2022

Professor Laura Empson pulls back the curtain on insecure overachieving professionals and explains how they can come to accept damaging patterns of overwork as inevitable and even desirable.

98

98

Impetus Digital

SEPTEMBER 16, 2022

In this Customer Story, we share how a nephrology brand team approached Impetus Digital for help with streamlining and optimizing their annual brand planning and strategic discussions. In the early parts of the pandemic, they had attempted to host these meetings themselves over a standard web meeting platform. While they understood the benefits of virtual, they found it difficult to align and reach consensus through their current approach due to a lack of an integrated view of all moving parts a

Pharma 97

Pharma 97

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

Pharmaceutical Technology

SEPTEMBER 12, 2022

The US Food and Drug Administration (FDA) has granted approval for Bristol Myers Squibb ’s (BMS) Sotyktu (deucravacitinib) to treat adult patients with moderate-to-severe plaque psoriasis. The oral treatment is indicated for such patients who are candidates for systemic therapy or phototherapy. It should not be used along with other immunosuppressants.

Food and Drug Administration 98

Food and Drug Administration FDA Food Safety 98

MedCity News

SEPTEMBER 12, 2022

Retail pharmacy chains and Amazon are transforming themselves into omnichannel healthcare providers, developing primary care services and virtual tools through acquisitions, partnerships and investments.

Retail 97

Retail Healthcare Provider Healthcare Healthcare 97

pharmaphorum

SEPTEMBER 11, 2022

A personalised cell therapy based on tumour-infiltrating lymphocyte (TIL) cells has been shown to be more effective at improving progression-free survival than Bristol-Myers Squibb’s immunotherapy Yervoy in patients with advanced melanoma. It is the first time that a cell therapy for solid tumours has been tested in a phase 3 trial, and the first time that the approach has been directly compared with standard second-line immunotherapy in melanoma.

Side effects 98

Side effects Patients Engineering Management 98

Copyright Clearance Center

SEPTEMBER 15, 2022

The post Fueling Your AI & Machine Learning Projects with XML Content – Why Flexible Retrieval Options Are Crucial?? appeared first on Copyright Clearance Center.

98

98

Advertiser: ZoomInfo

In times of economic uncertainty, account-based strategies are essential. According to several business analysts and practitioners, ABM is a necessity for creating more predictable revenue. Research shows that nearly three-quarters of marketers (74%) already have the resources needed to build successful ABM programs.

Marketing